Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM
Syeda Sumayya Tariq, Muhammad Salman Haleem, Reaz Uddin · 2026
Read Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM by Syeda Sumayya Tariq, Muhammad Salman Haleem, Reaz Uddin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213580.txt.
Description
Syeda Sumayya Tariq, Muhammad Salman Haleem, and Reaz Uddin use in 2026 a type of AI that writes new drug shapes the way chat tools write text. Their foe is a germ enzyme that breaks carbapenem drugs, among the last strong antibiotics doctors hold in reserve.
They trained the tool on millions of known compounds. All of the shapes it wrote were sound, most passed the usual rules for drug-like traits, and few raised harm flags. The team then docked the best shapes into the enzyme on a computer and ran long motion sims. Four shapes held firm and gripped the enzyme about as well as a drug now in use. The same path could hunt drugs for other germ enzymes.
Catalog record
| CREATOR | Syeda Sumayya Tariq, Muhammad Salman Haleem, Reaz Uddin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |